Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker AKTS
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| May 14, 2026 | SCHEDULE 13G | AKTS Aktis Oncology, Inc. | Blue Owl Capital Holdings LP | 3.16M | 5.9% | SCHEDULE 13G ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | Todd Foley | 4.24M | 8.0% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | Luke Evnin | 5.08M | 9.5% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | Ansbert Gadicke | 10.26M | 19.3% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | MPM Asset Management LLC | 341,709 | 0.6% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | MPM Oncology Investments 2 LLC | 4.84M | 9.1% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | Oncology Impact Private Investment Fund 2, L.P. | 4.84M | 9.1% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | MPM Oncology Innovations Fund GP LLC | 847,080 | 1.6% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | MPM Oncology Innovations Fund LP | 847,080 | 1.6% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | MPM BioVentures 2018 LLC | 4.24M | 7.9% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | MPM Asset Management Investors BV2018 LLC | 77,911 | 0.1% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | MPM BioVentures 2018 GP LLC | 4.16M | 7.8% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | MPM Bioventures 2018 (B), L.P. | 206,964 | 0.4% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | MPM Bioventures 2018, L.P. | 3.95M | 7.4% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | EcoR1 Capital Fund Qualified, L.P. | 4.35M | 8.2% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | Oleg Nodelman | 4.86M | 9.1% | SCHEDULE 13D ↗ |
| Jan 20, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | EcoR1 Capital, LLC | 4.82M | 9.1% | SCHEDULE 13D ↗ |
| Jan 15, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | Eli Lilly and Company | 6.34M | 11.9% | SCHEDULE 13D ↗ |
| Jan 14, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | Helen Kim | 5.83M | 10.9% | SCHEDULE 13D ↗ |
| Jan 14, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | VV Manager II LLC | 5.83M | 10.9% | SCHEDULE 13D ↗ |
| Jan 14, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | Vida Ventures II-A, LLC | 157,387 | 0.3% | SCHEDULE 13D ↗ |
| Jan 14, 2026 | SCHEDULE 13D | AKTS Aktis Oncology, Inc. | Vida Ventures II, LLC | 5.67M | 10.6% | SCHEDULE 13D ↗ |
22 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 11:28 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances